Get all your news in one place.
100's of premium titles.
One app.
Start reading
Barchart
Barchart
Neharika Jain

FOUND: Resmed s quarterly earnings preview what you need to know - You Need To See This

Based in San Diego, California, ResMed Inc. (RMD) develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. Valued at a market cap of $33.6 billion, the company primarily provides generators, masks, and related accessories for the treatment of sleep-disordered breathing (SDB) and other respiratory disorders. It is scheduled to announce its fiscal Q2 earnings results on Wednesday, Jan. 22. 

Before this event, analysts projected the medical instruments provider to report a profit of $2.29 per share, up 21.8% from $1.88 per share in the year-ago quarter. Moreover, the company has a promising trajectory of consistently beating Wall Street's bottom-line estimates in the last four quarters. In Q1 2025, RMD’s adjusted EPS of $2.20 outpaced the consensus estimates by 8.4%. 

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.